Owczarczyk, K., D. Passon, T. Roehrs, N. Jung, D. Taubert, G. Valet and A. Rubbert: Circulating CD22+CD20-CD19+ cells at baseline may predict the clinical response to rituximab in patients with active RA.. In: Zeitschrift fur Rheumatologie 66, Suppl. Suppl. 1, 40-40 (2007).
The Max Planck Society does not take any responsibility for the content of this export.